Centene Corporation (NYSE:CNC - Get Free Report) saw unusually-strong trading volume on Monday . Approximately 6,671,054 shares were traded during trading, an increase of 22% from the previous session's volume of 5,466,049 shares.The stock last traded at $33.24 and had previously closed at $33.31.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on the stock. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $48.00 target price (down previously from $75.00) on shares of Centene in a report on Wednesday, July 2nd. Barclays lowered their target price on Centene from $65.00 to $45.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 2nd. Jefferies Financial Group lowered their target price on Centene from $64.00 to $61.00 and set a "hold" rating for the company in a research note on Tuesday, April 29th. UBS Group reissued a "neutral" rating and set a $45.00 target price (down from $80.00) on shares of Centene in a research note on Wednesday, July 2nd. Finally, Robert W. Baird decreased their price target on Centene from $71.00 to $69.00 and set a "neutral" rating for the company in a report on Tuesday, April 15th. Ten analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, Centene currently has a consensus rating of "Hold" and a consensus target price of $68.87.
Read Our Latest Report on Centene
Centene Trading Down 0.8%
The company has a 50 day simple moving average of $55.40 and a 200 day simple moving average of $58.85. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $16.31 billion, a PE ratio of 4.89, a P/E/G ratio of 0.45 and a beta of 0.44.
Centene (NYSE:CNC - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.52 by $0.38. The firm had revenue of $46.62 billion during the quarter, compared to the consensus estimate of $43.16 billion. Centene had a return on equity of 14.56% and a net margin of 2.04%. The firm's revenue was up 15.4% compared to the same quarter last year. During the same period in the prior year, the business earned $2.26 EPS. Analysts predict that Centene Corporation will post 6.86 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Centene
Large investors have recently modified their holdings of the business. Pinney & Scofield Inc. purchased a new position in shares of Centene during the 4th quarter worth approximately $25,000. Hurley Capital LLC purchased a new position in shares of Centene during the 4th quarter worth approximately $26,000. Ameriflex Group Inc. purchased a new position in shares of Centene during the 4th quarter worth approximately $26,000. Quarry LP purchased a new position in shares of Centene during the 1st quarter worth approximately $26,000. Finally, Rialto Wealth Management LLC purchased a new position in shares of Centene during the 4th quarter worth approximately $30,000. 93.63% of the stock is owned by hedge funds and other institutional investors.
About Centene
(
Get Free Report)
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Stories
Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.